Browsing by Author Lloyd, D

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 2 to 8 of 8 < previous 
TitleAuthor(s)Issue DateViews
 
The effect of rTMS on auditory processing in adults with chronic, bilateral tinnitus: a placebo-controlled pilot study
Journal:Brain Stimulation: basic, translational and clinical research in neuromodulation
Barwood, CHSWilson, WJMalicka, ANMcPherson, DBLloyd, DMunt, KMurdoch, BE
2013
 
Final results of a phase I/II dose escalation trial of valtorcitabine in patients with chronic hepatitis B
Proceeding/Conference:Journal of Hepatology
Lim, SGLai, CLMyers, MYuen, RMFWai, CTLloyd, DPietropalolo, KZhou, XJChao, GBrown, NA
2005
210
 
Phase Iib Extended-Treatment Trial of Telbivudine (LdT) Vs Lamivudine Vs Combination Treatment in Hepatitis B Patients: Two-Year Results
Proceeding/Conference:Gastroenterology
Lai, CLLeung, NWTeo, EKTong, MWong, FHann, HWYHan, SHPoynard, TQiao, XPietropaolo, KLloyd, DBrown, NA
2005
 
Results of a One-year International Phase IIB Comparative Trial of Telbivudine, Lamivudine, and the Combination, in Patients with Chronic Hepatitis B
Proceeding/Conference:Hepatology
Lai, CLLeung, NWYTeo, EKTong, MWong, FHann, HWHan, SPoynard, TMyers, MChao, GLloyd, DBrown, N
2003
 
Safety and Antiviral Effects of Val-LdC and LdT in Patients with Chronic Hepatitis B
Proceeding/Conference:Asian Pacific Association for the Study of the Liver Meeting
Lim, SGYoung, DYYuen, MFMyers, MLloyd, DBrown, NLai, CL
2002
 
Val-LdT: First evidence of efficacy and safety for a new anti-HBV agent
Proceeding/Conference:Digestive Disease Week
Lim, SGLai, CLYuen, RMFBrown, NLloyd, DMyers, M
2002
 
Valtorcitabine provides potent suppression of hepatitis B virus in patients with chronic hepatitis B: Results of a phase I/II clinical trial
Proceeding/Conference:Hepatology
Lai, CLBrown, NAYuen, RMFWai, CTLloyd, DPietropaolo, KZhou, XJChao, GLim, SG
2004
121
Showing results 2 to 8 of 8 < previous